Quick Answer
Vaxart, Inc. reported Total Revenue of $237.26 million for fiscal year 2025.
Vaxart, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $237.26M | +726.7% |
| 2024 | $28.70M | +288.9% |
| 2023 | $7.38M | +77.4% |
| 2018 | $4.16M | -28.8% |
| 2017 | $5.84M | -34.4% |
| 2017 | $8.90M | -4.3% |
| 2016 | $9.30M | -62.2% |
| 2015 | $24.60M | -64.2% |
| 2014 | $68.70M | +104.5% |
| 2013 | $33.60M | +64.7% |
| 2012 | $20.40M | +37.5% |
| 2011 | $14.84M | +18.7% |
| 2011 | $12.50M | -64.3% |
| 2010 | $35.01M | +233.7% |
| 2009 | $10.49M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $72.41M | +1367.9% | +82.3% |
| June 30, 2025 | $39.73M | +520.7% | +90.3% |
| March 31, 2025 | $20.88M | +857.2% | +323.2% |
| September 30, 2024 | $4.93M | +134.8% | -22.9% |
| June 30, 2024 | $6.40M | +371.4% | +193.5% |
| March 31, 2024 | $2.18M | +223.1% | +3.8% |
| September 30, 2023 | $2.10M | — | +54.7% |
| June 30, 2023 | $1.36M | — | +101.2% |
- Vaxart, Inc. showed an increase of +726.7% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, Vaxart, Inc.’s total revenue has grown by 2162.0% (from $10.49 million to $237.26 million).
- The most recent figure is from Vaxart, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: